Paid Clinical Trials for Glioma

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing 21 – 35 of 35 results

Safusidenib Phase 2 Study in IDH1 Mutant Glioma

by CTG

in Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4

Other

Alabama

Deadline:

03/01/2028

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

by CTG

in Glioma, Anaplastic Astrocytoma, Diffuse Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma

Other

Alabama

Deadline:

06/01/2027

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

by CTG

in Glioma, Brain Tumor, Astrocytoma, Malignant Glioma of Brain, Malignant Astrocytoma

Other

Michigan

Deadline:

12/01/2027

A Study of 177Lu-PSMA-617 in People With Gliomas

by CTG

in Glioblastoma, IDH-wildtype, Glioma, Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4), Diffuse Midline Glioma, H3 K27-Altered, Diffuse Hemispheric Glioma, H3 G34-mutant

Other

New Jersey

Deadline:

10/01/2027

18F-Fluciclovine PET-MRI in High-grade Glioma

by CTG

in Glioma, Glioma, Malignant, High Grade Glioma, Glioma Intracranial, Diffuse Glioma

Other

Pennsylvania

Deadline:

12/01/2027

Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease

by CTG

in Glioma

Other

Minnesota

Deadline:

09/01/2027

rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide

by CTG

in Glioma

Other

Missouri

Deadline:

04/13/2028

rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide

by CTG

in Glioma

Other

Missouri

Deadline:

04/13/2028

Assessing Brain Metabolism Using MRS With Deuterated Glucose

by CTG

in Glioma

Other

California

Deadline:

07/31/2027

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

by CTG

in Brain Cancer, Glioma, High Grade Glioma, HGG, High Grade Gliomas

Other

Tennessee

Deadline:

01/01/2031

Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas

by CTG

in Glioma

Other

Maryland

Deadline:

12/31/2027

Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype

by CTG

in Glioblastoma, Glioma, Malignant Glioma, Low Grade Glioma, High Grage Glioma

Other

Maryland

Deadline:

02/27/2026

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

by CTG

in Glioblastoma, Glioblastoma Multiforme, Glioma, Glioma, Malignant, Glioblastoma Multiforme of Brain

Other

New York

Deadline:

04/01/2027

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

by CTG

in Glioma, IDH Mutation, Astrocytoma, Oligodendroglioma

Other

Pennsylvania

Deadline:

06/01/2027

LITT Followed by Hypofractionated RT for Recurrent Gliomas

by CTG

in Glioblastoma, Glioma, Brain Tumor, Neoplasms

Other

Maryland

Deadline:

12/01/2026